CK-MB Detection Kit: Precision in Cardiac Diagnosis
The CK-MB detection kit quantifies CK-MB levels in human serum using a chemiluminescence immunoassay (CLIA). With a detection range of 0.1–250.0 ng/mL, it enables early and accurate diagnosis of myocardial infarction (MI) and other cardiac conditions, ensuring reliability through Beckman CK-MB assay calibration and compatibility with multiple analyzers.
-
The CK-MB detection kit quantifies CK-MB levels in human serum, aiding in the diagnosis of myocardial infarction (MI) and cardiac conditions. Utilizing chemiluminescence immunoassay (CLIA) with a detection range of 0.1–250.0 ng/mL, the kit offers high sensitivity, early detection (4–6 hours post-symptom onset), and compatibility with various analyzers. It is calibrated to the Beckman CK-MB assay, ensuring precision and reliability. Clinical evaluation is recommended for accurate diagnosis.